(7780) Stock Price

Menicon operates primarily through its Vision Care business and other business segments. The Vision Care business manufactures and sells contact lenses and care products, and also provides "Miru Plan," a subscription-based membership system. This plan includes services with coverage for loss and damage, and has 1.32 million members.

In the Vision Care business, Menicon manufactures and sells hard contact lenses, soft contact lenses, and disposable contact lenses (daily disposable, two-week replacement, and monthly replacement types). The company also manufactures and sells care products, operating production facilities both domestically and internationally, with particular focus on strengthening supply capacity for daily disposable contact lenses.

In other business segments, Menicon develops and sells veterinary medical products, agricultural and livestock materials, assisted reproductive medical products, and provides personnel dispatch services. The company also engages in sales, import, and export of agricultural and aquatic products. In the animal healthcare business, Menicon focuses on veterinary ophthalmology and collaborates with veterinarians to develop therapeutic devices and supplements for animals.

Menicon has expanded into the healthcare and life care sectors, with emphasis on femtech-related products and environmental businesses. The company manufactures and sells compost accelerator "ResQ," rice straw decomposition accelerator "Agri Revolution," and improved Japanese grass "Naru Turf." In the food business, through subsidiary Itabashi Trading Co., Ltd., the company imports and exports fresh fish and Japanese rice.

Menicon has established "Vision 2030" as its growth strategy, aiming to strengthen its presence in global markets. Under this plan, the company operates under the slogan "Bringing New Vision to the World," seeking to provide products and services that enable people to experience happiness and enrichment through their senses.

Menicon's medium-term management plan "Vision 2030" targets consolidated net sales exceeding 140 billion yen, an operating profit margin of 12%, and ROE of 12% by 2028. To achieve these goals, the company is strengthening production capacity for daily disposable contact lenses and expanding the market for orthokeratology-related products.

The company's growth strategy is divided into two pillars: the "1DAY Strategy" aimed at becoming a global top player in daily disposable contact lenses, and the "Orthokeratology-Related Strategy" that creates new value in myopia progression control. Through these initiatives, Menicon is strengthening product supply in response to market demand.

Menicon is focusing on its vision care business while also expanding healthcare and life care operations. The company prioritizes activities toward achieving a sustainable society, working to reduce environmental impact and contribute to local communities, thereby enhancing corporate value.

Additionally, the company is strengthening its governance structure and compliance framework, pursuing management stability through risk management. These efforts support sustained growth and long-term enhancement of corporate value.